← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2019Last known activity
Dec 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 13 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (29)
- NCT07208799Lead sponsorPhase 2Dec 1, 2025
- NCT07288801OfficialPhase 4Aug 9, 2025
- NCT07288801Sponsor investigatorPhase 4Aug 9, 2025
- NCT07288801Lead sponsorPhase 4Aug 9, 2025
- NCT07160855Sponsor investigatorPhase 4May 13, 2025
- NCT06997575Lead sponsorPhase 4May 13, 2025
- NCT07160855Lead sponsorPhase 4May 13, 2025
- NCT06997575Sponsor investigatorPhase 4May 13, 2025
- NCT07160855OfficialPhase 4May 13, 2025
- NCT06897969OfficialPhase 4Apr 1, 2025
- NCT06897969Sponsor investigatorPhase 4Apr 1, 2025
- NCT06897969Lead sponsorPhase 4Apr 1, 2025
- NCT06840379Lead sponsorN/AOct 15, 2024
- NCT06840379Sponsor investigatorN/AOct 15, 2024
- NCT06905496OfficialPhase 1Jun 3, 2024
Details
- Last known activity
- Dec 1, 2025